Cargando…
Identification of the key target profiles underlying the drugs of narrow therapeutic index for treating cancer and cardiovascular disease
An appropriate therapeutic index is crucial for drug discovery and development since narrow therapeutic index (NTI) drugs with slight dosage variation may induce severe adverse drug reactions or potential treatment failure. To date, the shared characteristics underlying the targets of NTI drugs have...
Autores principales: | Yin, Jiayi, Li, Xiaoxu, Li, Fengcheng, Lu, Yinjing, Zeng, Su, Zhu, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105181/ https://www.ncbi.nlm.nih.gov/pubmed/33995923 http://dx.doi.org/10.1016/j.csbj.2021.04.035 |
Ejemplares similares
-
VARIDT 1.0: variability of drug transporter database
por: Yin, Jiayi, et al.
Publicado: (2020) -
VARIDT 1.0: variability of drug transporter database
por: Yin, Jiayi, et al.
Publicado: (2020) -
Equivalence and interchangeability of narrow therapeutic index drugs in organ transplantation
por: Johnston, Atholl
Publicado: (2013) -
INTEDE: interactome of drug-metabolizing enzymes
por: Yin, Jiayi, et al.
Publicado: (2020) -
Drugs with narrow therapeutic index as indicators in the risk management of hospitalised patients
por: Blix, Hege S., et al.
Publicado: (2010)